Filtered By:
Drug: Medroxyprogesterone
This page shows you your search results in order of date. This is page number 5.
Order by Relevance | Date
Total 487 results found since Jan 2013.
Is self-administered DMPA an answer to contraception access in the post-Roe era?
J Fam Pract. 2023 Mar;72(2):84-86. doi: 10.12788/jfp.0558.ABSTRACTCompared with provider-administered depot medroxyprogesterone acetate, a prefilled formulation may offer patients improved access to effective contraception.PMID:36947783 | PMC:PMC10032666 | DOI:10.12788/jfp.0558
Source: The Journal of Family Practice - March 22, 2023 Category: Practice Management Authors: Lindsay Nakaishi Gregory Castelli Source Type: research
Effects of a fertility-sparing re-treatment for recurrent atypical endometrial hyperplasia and endometrial cancer: a systematic literature review
J Gynecol Oncol. 2023 Mar 6. doi: 10.3802/jgo.2023.34.e49. Online ahead of print.ABSTRACTTo examine the effectiveness of progestin re-treatment for recurrent endometrial intraepithelial neoplasia (EIN), atypical endometrial hyperplasia (AH) and endometrial cancer (EC) following initial fertility-sparing treatment. A comprehensive systematic review and meta-analysis were conducted by an Expert Panel of the Japan Society of Gynecologic Oncology Endometrial Cancer Committee. Multiple search engines, including PubMed/MEDLINE and the Cochrane Database, were searched in December 2021 using the keywords "Endometrial neoplasms," "...
Source: Journal of Gynecologic Oncology - March 17, 2023 Category: OBGYN Authors: Isao Murakami Hiroko Machida Tohru Morisada Yasuhisa Terao Tsutomu Tabata Mikio Mikami Yasuyuki Hirashima Yoichi Kobayashi Tsukasa Baba Satoru Nagase Source Type: research
